Subject Index to Volume 3
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
4
Page:
65-69
Author(s):
Bentham Science Publishers
Hypoxia Inducible Factor as a Cancer Drug Target
Journal:
Current Cancer Drug Targets
Volume:
3
Page:
391-405
Author(s):
Sarah J. Welsh and Garth Powis
Nitric Oxide-Releasing Non Steroidal Anti-Inflammatory Drugs: A New Generation of Anti-Tumoral Molecules
Journal:
Current Cancer Drug Targets
Volume:
3
Page:
407-426
Author(s):
Christian Lavagna, Piero Del Soldato, Jean-Luc Burgaud and Patrick Rampal
Emerging Role of Endoglin (CD105) as a Marker of Angiogenesis with Clinical Potential in Human Malignancies
Journal:
Current Cancer Drug Targets
Volume:
3
Page:
427-432
Author(s):
E. Fonsatti, L. Sigalotti, P. Arslan, M. Altomonte and M. Maio
Thomsen-Friedenreich Disaccharide Immunogenicity
Journal:
Current Cancer Drug Targets
Volume:
3
Page:
433-443
Author(s):
Fernando J. Irazoqui and Gustavo A. Nores
Metabolic Biomarker and Kinase Drug Target Discovery in Cancer Using Stable Isotope-Based Dynamic Metabolic Profiling (SIDMAP)
Journal:
Current Cancer Drug Targets
Volume:
3
Page:
445-453
Author(s):
Laszlo G. Boros, Daniel J. Brackett and George G. Harrigan
Cyclooxygenase Inhibition and Mechanisms of Colorectal Cancer Prevention
Journal:
Current Cancer Drug Targets
Volume:
3
Page:
455-463
Author(s):
Timothy A. Chan
Biosafety of Onco-Retroviral Vectors
Journal:
Current Gene Therapy
Volume:
3
Page:
501-515
Author(s):
Thierry VandenDriessche, Desire Collen and Marinee K.L. Chuah
Biosafety of Adenoviral Vectors
Journal:
Current Gene Therapy
Volume:
3
Page:
527-543
Author(s):
Marinee K.L. Chuah, Desire Collen and Thierry VandenDriessche
Evaluation of Risks Related to the Use of Adeno-Associated Virus-Based Vectors
Journal:
Current Gene Therapy
Volume:
3
Page:
545-565
Author(s):
L. Tenenbaum, E. Lehtonen and P. E. Monahan